Composition for preventing or treating sars coronavirus 2 infection disease
A technology for respiratory syndrome and coronavirus, applied in respiratory diseases, drug combinations, antiviral agents, etc., can solve the problems of unpublished prevention or treatment of coronavirus infection, and achieve the effect of preventing or improving the diseases caused by
Pending Publication Date: 2021-12-21
シンテカバイオ インコーポレイティッド
View PDF2 Cites 0 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0007] As technologies related to pharmaceutical compositions for improving or treating coronavirus infections, Korean Patent No. 1913789 discloses compounds for treating diseases caused by coronavirus infections, and U.S. Laid-Open Patent No. 2006-0257852 discloses Technology related to severe acute respiratory syndrome coronavirus, but does not disclose the composition of the present invention for preventing or treating coronavirus infection, which contains the activity inhibitor of coronavirus 3CL protease as an active ingredient
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
preparation example 1
[0102] Preparation example 1. Zafirlukast (Zafirlukast)
[0103] Commercially available zafirlukast (CAS Number: 107753-78-6) was used.
preparation example 2
[0104] Preparation example 2. Sulfinpyrazone (Sulfinpyrazone)
[0105] Commercially available sulfinpyrazone (CAS Number: 57-96-5) was used.
preparation example 3
[0106] Preparation example 3. Combined use of zafirlukast and sulfinpyrazone
[0107] The above-mentioned zafirlukast and sulfinpyrazone are used in combination.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
Disclosed is a pharmaceutical composition for preventing or treating severe acute respiratory syndrome coronavirus 2 infection disease, the composition comprising a compound represented by a Chemical Formula 1, or a pharmaceutically acceptable salt thereof, as an active ingredient.
Description
technical field [0001] The present invention relates to a composition for preventing or treating severe acute respiratory syndrome coronavirus 2 infection or diseases caused by severe acute respiratory syndrome coronavirus 2 infection. Background technique [0002] Severe acute respiratory syndrome coronavirus 2 is also known as COVID-19, SARS-CoV-2, 2019-nCoV virus. The World Health Organization (WHO) declared a public health emergency of international concern (PHEIC) in response to COVID-19, and on March 11, 2020, declared COVID-19 as a follow-up to Hong Kong influenza (1968) and influenza A (H1N1) (2009). global pandemic. COVID-19 is transmitted when droplets (saliva) from an infected person penetrate the respiratory tract or the mucous membranes of the eyes, nose and mouth. And when infected, after an incubation period of 2 to 14 days (estimated), respiratory symptoms such as fever, cough or dyspnea, and main symptoms such as pneumonia will appear, but occasionally asy...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/4152A23L33/10A23L2/52A23F3/16A23F3/14A61P11/00A61P31/14C12G3/05A61K31/4045
CPCA61K31/4045A61K31/4152A61P31/14A61P11/00A23L33/10A23L2/52A23F3/14A23F3/163C12G3/05A23V2002/00A61K2300/00A23V2200/314A61K31/404A23V2200/324A23V2250/30A61K31/405A61K9/0073A61K9/0053A61K9/0043
Inventor 郑钟善洪宗喜金东明朴奉焕柳永培权亨俊李仁哲朴智英
Owner シンテカバイオ インコーポレイティッド
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com